Seres Therapeutics
MCRB
MCRB
77 hedge funds and large institutions have $242M invested in Seres Therapeutics in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 79 → 77 (-2)
Holders
77
Holding in Top 10
2
Calls
$3K
Puts
–
Top Buyers
| 1 | +$4.9M | |
| 2 | +$2.26M | |
| 3 | +$1.8M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$574K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$518K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$791K | |
| 3 | -$775K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$494K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$432K |